Daisuke Aoki

16.9k total citations · 5 hit papers
440 papers, 11.0k citations indexed

About

Daisuke Aoki is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Daisuke Aoki has authored 440 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Reproductive Medicine, 135 papers in Obstetrics and Gynecology and 128 papers in Molecular Biology. Recurrent topics in Daisuke Aoki's work include Ovarian cancer diagnosis and treatment (130 papers), Endometrial and Cervical Cancer Treatments (121 papers) and Cervical Cancer and HPV Research (54 papers). Daisuke Aoki is often cited by papers focused on Ovarian cancer diagnosis and treatment (130 papers), Endometrial and Cervical Cancer Treatments (121 papers) and Cervical Cancer and HPV Research (54 papers). Daisuke Aoki collaborates with scholars based in Japan, United States and United Kingdom. Daisuke Aoki's co-authors include Kouji Banno, Rengaswamy Sankaranarayanan, Neerja Bhatla, Daya Nand Sharma, Nobuyuki Susumu, Akira Hirasawa, Wataru Yamagami, Megumi Yanokura, Iori Kisu and Eiichiro Tominaga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Daisuke Aoki

432 papers receiving 10.8k citations

Hit Papers

Cancer of the cervix uteri 2009 2026 2014 2020 2018 2009 2021 2013 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer of the cervix uteri
    2018 752 citations Daisuke Aoki et al. International Journal of Gynecology & Obstetrics profile →
  2. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
    2009 502 citations Fumiaki Takahashi, Daisuke Aoki et al. profile →
  3. Endometrial cancer
    2021 340 citations Daisuke Aoki et al. profile →
  4. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
    2013 331 citations Fumiaki Takahashi, Daisuke Aoki et al. profile →
  5. Cancer of the cervix uteri: 2021 update
    2021 282 citations Daisuke Aoki et al. International Journal of Gynecology & Obstetrics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daisuke Aoki 3.6k 3.6k 3.5k 2.5k 2.0k 440 11.0k
Ross S. Berkowitz 5.4k 1.5× 4.6k 1.3× 2.9k 0.8× 2.7k 1.1× 2.2k 1.1× 445 18.7k
Christian Marth 3.1k 0.9× 5.8k 1.6× 2.2k 0.6× 5.3k 2.1× 2.8k 1.4× 411 14.0k
Rainer Kimmig 3.6k 1.0× 2.2k 0.6× 1.8k 0.5× 3.6k 1.4× 2.3k 1.2× 402 10.3k
Xavier Matías‐Guiu 3.8k 1.1× 6.4k 1.8× 4.1k 1.2× 4.2k 1.7× 3.5k 1.8× 435 16.1k
Harry Hollema 1.8k 0.5× 3.5k 1.0× 2.3k 0.7× 4.0k 1.6× 2.3k 1.2× 229 11.9k
Janet S. Rader 1.8k 0.5× 3.1k 0.8× 2.6k 0.8× 1.8k 0.7× 2.3k 1.2× 210 8.4k
Alessandro D. Santin 2.0k 0.6× 3.2k 0.9× 2.0k 0.6× 4.6k 1.8× 1.4k 0.7× 353 10.6k
Gunnar B. Kristensen 7.6k 2.1× 3.6k 1.0× 4.4k 1.3× 4.3k 1.7× 2.2k 1.1× 266 14.7k
Russell R. Broaddus 3.4k 0.9× 5.8k 1.6× 3.6k 1.0× 4.9k 1.9× 4.4k 2.2× 286 15.1k
Peter Kenemans 2.7k 0.7× 2.6k 0.7× 1.5k 0.4× 2.4k 1.0× 780 0.4× 304 11.6k

Countries citing papers authored by Daisuke Aoki

Since Specialization
Citations

This map shows the geographic impact of Daisuke Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Aoki more than expected).

Fields of papers citing papers by Daisuke Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Aoki. The network helps show where Daisuke Aoki may publish in the future.

Co-authorship network of co-authors of Daisuke Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Aoki. A scholar is included among the top collaborators of Daisuke Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Aoki. Daisuke Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Machida, Hiroko, Koji Matsuo, Takahiro Higashi, et al.. (2024). Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan. Journal of Gynecologic Oncology. 35(5). e61–e61.
2.
Tanaka, Kyoko, Isao Murakami, Mikio Mikami, Daisuke Aoki, & Masao Iwamori. (2023). Reduced expression of gangliosides with GM2-determinant in cervical carcinoma-derived cells after subcutaneous transplantation into nude mice. Human Cell. 36(3). 1199–1203. 1 indexed citations
3.
Yamagami, Wataru, Miho Kawaida, Kensuke Sakai, et al.. (2022). Evaluation of the role of intraoperative frozen section and magnetic resonance imaging in endometrial cancer. International Journal of Gynecology & Obstetrics. 160(2). 554–562. 2 indexed citations
4.
Chiyoda, Tatsuyuki, Mio Takahashi, Kensuke Sakai, et al.. (2022). Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer. International Journal of Clinical Oncology. 27(10). 1644–1650. 5 indexed citations
5.
Sakai, Kensuke, Wataru Yamagami, Takeshi Makabe, et al.. (2021). Atypical vessels in hysteroscopy: Usefulness in prediction of malignant diseases in patients treated with tamoxifen. Journal of obstetrics and gynaecology research. 47(4). 1510–1515. 1 indexed citations
6.
7.
Morisada, Tohru, Kumiko Saika, Etsuko Miyagi, et al.. (2021). The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate. Journal of Gynecologic Oncology. 32(3). e29–e29. 5 indexed citations
8.
Machida, Hiroko, Koji Matsuo, Koji Oba, et al.. (2021). Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study. Journal of Gynecologic Oncology. 33(1). e3–e3. 5 indexed citations
9.
Sakai, Kensuke, Wataru Yamagami, Hiroko Machida, et al.. (2021). A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapy. International Journal of Gynecology & Obstetrics. 156(2). 262–269. 2 indexed citations
10.
Tokunaga, Hideki, Mikio Mikami, Satoru Nagase, et al.. (2021). The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. Journal of Gynecologic Oncology. 32(2). e49–e49. 34 indexed citations
11.
Nishio, Hiroshi, Takashi Iwata, & Daisuke Aoki. (2020). Current status of cancer immunotherapy for gynecologic malignancies. Japanese Journal of Clinical Oncology. 51(2). 167–172. 18 indexed citations
12.
Harada, Miyuki, Chisato Kunitomi, Gentaro Izumi, et al.. (2019). A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. Journal of obstetrics and gynaecology research. 45(10). 2021–2028. 16 indexed citations
13.
Okazaki, Shogo, Kiyoko Umene, Juntaro Yamasaki, et al.. (2019). Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma. Cancer Science. 110(11). 3453–3463. 62 indexed citations
14.
Kunitomi, Haruko, Yusuke Kobayashi, Ren‐Chin Wu, et al.. (2019). LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer. Journal of Gynecologic Oncology. 31(2). e11–e11. 40 indexed citations
15.
Yamagami, Wataru, Nobuyuki Susumu, Takeshi Makabe, et al.. (2018). Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?. Journal of Gynecologic Oncology. 29(2). e21–e21. 51 indexed citations
16.
Morisada, Tohru, Hirokuni Takano, Ikuko Sakamoto, et al.. (2017). CITRUS, cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening: Design, methods and baseline data of 18,471 women. Cancer Epidemiology. 50(Pt A). 60–67. 11 indexed citations
17.
Ueki, Arisa, Iori Kisu, Kouji Banno, et al.. (2011). Gynecological tumors in patients with Peutz-Jeghers syndrome (PJS). 1(3). 65–69. 8 indexed citations
18.
Tsuruta, Tomohiko, Ken‐ichi Kozaki, Atsushi Uesugi, et al.. (2011). miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer. Cancer Research. 71(20). 6450–6462. 185 indexed citations
19.
Aoki, Daisuke, Yoshinao Oda, Satoshi Hattori, et al.. (2009). Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma. Clinical Cancer Research. 15(4). 1473–1480. 55 indexed citations
20.
Sugihara, Kazuhiro, Daijiro Sugiyama, James Byrne, et al.. (2007). Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation. Proceedings of the National Academy of Sciences. 104(10). 3799–3804. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ross S. Berkowitz Breakdown of academic impact, for papers by Christian Marth Breakdown of academic impact, for papers by Rainer Kimmig Breakdown of academic impact, for papers by Xavier Matías‐Guiu Breakdown of academic impact, for papers by Harry Hollema Breakdown of academic impact, for papers by Janet S. Rader Breakdown of academic impact, for papers by Alessandro D. Santin Breakdown of academic impact, for papers by Gunnar B. Kristensen Breakdown of academic impact, for papers by Russell R. Broaddus Breakdown of academic impact, for papers by Peter Kenemans
Rankless by CCL
2026